Among different maternal metabolic risk factors, fasting maternal insulin levels in pregnant mothers with obesity at 18-20gw were associated with the abdominal/total FMr in newborns, a known predictor of cardiometabolic risk later in life. The gene discussed is INS; the disease is obesity disorder.